Your browser doesn't support javascript.
loading
The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies.
Peng, Qiu-Yue; An, Ying; Jiang, Zong-Zhe; Xu, Yong.
Afiliación
  • Peng QY; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
  • An Y; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Sichuan, People's Republic of China.
  • Jiang ZZ; Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, People's Republic of China.
  • Xu Y; Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
J Inflamm Res ; 17: 2103-2118, 2024.
Article en En | MEDLINE | ID: mdl-38601771
ABSTRACT
Diabetic kidney disease (DKD), is a common microvascular complication and a major cause of death in patients with diabetes. Disorders of immune cells and immune cytokines can accelerate DKD development of in a number of ways. As the kidney is composed of complex and highly differentiated cells, the interactions among different cell types and immune cells play important regulatory roles in disease development. Here, we summarize the latest research into the molecular mechanisms underlying the interactions among various immune and renal cells in DKD. In addition, we discuss the most recent studies related to single cell technology and bioinformatics analysis in the field of DKD. The aims of our review were to explore immune cells as potential therapeutic targets in DKD and provide some guidance for future clinical treatments.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Inflamm Res Año: 2024 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Inflamm Res Año: 2024 Tipo del documento: Article Pais de publicación: Nueva Zelanda